Published in Qual Saf Health Care on June 01, 2004
The impact of a closed-loop electronic prescribing and administration system on prescribing errors, administration errors and staff time: a before-and-after study. Qual Saf Health Care (2007) 2.18
A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems. J Am Med Inform Assoc (2010) 2.10
Medication errors: definitions and classification. Br J Clin Pharmacol (2009) 1.97
What is the scale of prescribing errors committed by junior doctors? A systematic review. Br J Clin Pharmacol (2008) 1.73
Medication errors: the importance of an accurate drug history. Br J Clin Pharmacol (2009) 1.52
Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts. J Am Med Inform Assoc (2012) 1.11
The influence of computerized decision support on prescribing during ward-rounds: are the decision-makers targeted? J Am Med Inform Assoc (2011) 1.05
Medication error identification rates by pharmacy, medical, and nursing students. Am J Pharm Educ (2011) 0.91
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop. BMC Med Inform Decis Mak (2013) 0.90
Triaging patients at risk of influenza using a patient portal. J Am Med Inform Assoc (2011) 0.81
Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA (1998) 23.39
Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA (1995) 20.12
Causes of prescribing errors in hospital inpatients: a prospective study. Lancet (2002) 10.74
Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ (2000) 5.23
GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther (2002) 4.23
Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care (2002) 3.55
Illegible handwriting in medical records. J R Soc Med (2002) 3.17
Improving the quality of the order-writing process for inpatient orders and outpatient prescriptions. Am J Health Syst Pharm (2000) 1.55
Using trade names: sometimes it helps. Arch Intern Med (2002) 0.94
Newly licensed drugs. BMJ (1996) 6.68
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23
Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ (2000) 5.23
Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ (2001) 3.53
Joining the DoTS: new approach to classifying adverse drug reactions. BMJ (2003) 3.47
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02
Is there a cure for drug errors? BMJ (1995) 2.55
Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med (2009) 2.38
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) (2008) 2.15
Misleading drug packaging. BMJ (1995) 2.12
Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int (1999) 2.10
The evidence base for the treatment of lupus nephritis in the new millennium. Nephrol Dial Transplant (2001) 2.04
Primary systemic vasculitis. Lancet (1997) 1.94
'The strategy of desire' and rational prescribing. Br J Clin Pharmacol (1994) 1.84
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
Modifying the request behaviour of clinicians. J Clin Pathol (1992) 1.78
The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant (2001) 1.75
Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int (2001) 1.67
Minocycline for acne. BMJ (1996) 1.61
Rate of progression of lung function impairment in alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.61
Effect of educational feedback on clinicians' requesting of cardiac enzymes. Ann Clin Biochem (1992) 1.55
Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant (1992) 1.54
Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens (2007) 1.54
Non-steroidal anti-inflammatory drugs and renal failure. Lancet (1986) 1.52
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation (1998) 1.49
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46
Why are thiazide diuretics declining in popularity? J Hum Hypertens (2001) 1.44
Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM (2000) 1.44
Hypercalcaemia: changing causes over the past 10 years. BMJ (1992) 1.43
Lead poisoning from Asian traditional remedies in the West Midlands--report of a series of five cases. Hum Exp Toxicol (1995) 1.42
Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant (1997) 1.41
Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther (2002) 1.40
Feedback of laboratory usage and cost data to clinicians: does it alter requesting behaviour? Ann Clin Biochem (1991) 1.39
Amyloidosis in continuous ambulatory peritoneal dialysis. Postgrad Med J (1987) 1.39
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34
The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int (2006) 1.30
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet (1983) 1.27
Relapses in patients with a systemic vasculitis. Q J Med (1993) 1.27
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (2010) 1.27
IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol (1996) 1.26
Antineutrophil cytoplasmic antibodies induce reactive oxygen-dependent dysregulation of primed neutrophil apoptosis and clearance by macrophages. Am J Pathol (2000) 1.24
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther (2004) 1.23
Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant (1994) 1.20
Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant (2001) 1.20
Hazards, risks and reality. Br J Clin Pharmacol (1992) 1.20
A diffusible factor restoring contact inhibition of growth to malignant melanocytes. Proc Natl Acad Sci U S A (1974) 1.18
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and White British origin. Rheumatology (Oxford) (2008) 1.16
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Adverse drug reactions: who is to know? BMJ (1993) 1.13
Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol (2004) 1.11
DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus. Clin Exp Immunol (1981) 1.11
Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol (2001) 1.09
In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int (1998) 1.07
Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol (1990) 1.07
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol (2002) 1.05
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05
Comparative tolerability profiles of oral antidiabetic agents. Drug Saf (1994) 1.03
Evaluation of a shortened version of the Abbreviated Mental Test in a series of elderly patients. Clin Rehabil (1997) 1.02
Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg (2010) 1.02
Disinfection of hands and tubing of CAPD patients. J Hosp Infect (1984) 1.02
Hypertension and end-stage renal failure in tropical Africa. J Hum Hypertens (1993) 1.01
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet (1987) 1.01
Hemodialysis in the treatment of acute renal failure in tropical Africa: a 20-year review at the Korle Bu Teaching Hospital, Accra. Ren Fail (1996) 1.00
The influence of big pharma. BMJ (2005) 1.00
Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci (Lond) (1986) 0.99
The safety of spironolactone treatment in patients with heart failure. J Clin Pharm Ther (2003) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Use of information technology for auditing effective use of laboratory services. J Clin Pathol (1991) 0.98
Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet (1984) 0.98
Alcohol intake: measure for measure. BMJ (2001) 0.97
ABC of arterial and vascular disease: vasculitis. BMJ (2000) 0.97
Cognitive assessment in elderly patients admitted to hospital: the relationship between the Abbreviated Mental Test and the Mini-Mental State Examination. Clin Rehabil (1999) 0.97
T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol (1998) 0.97
Testing the practical aspects of therapeutics by objective structured clinical examination. J Clin Pharm Ther (2004) 0.97
Cytokines in haemolytic uraemic syndrome associated with verocytotoxin-producing Escherichia coli infection. Arch Dis Child (1997) 0.96
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM (2005) 0.96
Poisoning with anti-hypertensive drugs: calcium antagonists. J Hum Hypertens (1995) 0.96
Anti-idiotype and immunosuppressant treatment of murine lupus. Clin Exp Immunol (1991) 0.95
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Ann Rheum Dis (2004) 0.94
Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage fluid: report of 15 cases. J Clin Pathol (1986) 0.94
Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 0.93
Treatment of vasculitic IgA nephropathy. J Nephrol (2001) 0.93
Cognitive assessment in elderly patients admitted to hospital: the relationship between the shortened version of the Abbreviated Mental Test and the Abbreviated Mental Test and Mini-Mental State Examination. Clin Rehabil (2000) 0.93
Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM (1997) 0.92
Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila) (2014) 0.92
Renal biopsy findings in hypertensive patients with proteinuria. Lancet (1992) 0.92
No association between neutrophil FcgammaRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis. Clin Exp Immunol (1999) 0.91
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
Anabolic steroids: the power and the glory? BMJ (1988) 0.91
Powerful morphometric indicator of prognosis in lupus nephritis. QJM (2003) 0.90
Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med (1983) 0.90
Atropine treatment for baclofen overdose. Postgrad Med J (1981) 0.90